82 related articles for article (PubMed ID: 10705824)
1. Appropriateness of prostate-specific antigen testing.
Poteat HT; Chen P; Loughlin KR; Winkelman JW; Allada R; Ma'luf N; Tanasijevic MJ; Bates DW
Am J Clin Pathol; 2000 Mar; 113(3):421-8. PubMed ID: 10705824
[TBL] [Abstract][Full Text] [Related]
2. Practitioner-level determinants of inappropriate prostate-specific antigen screening.
Kerfoot BP; Holmberg EF; Lawler EV; Krupat E; Conlin PR
Arch Intern Med; 2007 Jul; 167(13):1367-72. PubMed ID: 17620529
[TBL] [Abstract][Full Text] [Related]
3. Physician clinical experience and inappropriate prostate specific antigen screening: evidence from an Asian country.
Kuo NW; Lin HC; Lee HC
J Urol; 2008 Nov; 180(5):1954-8; discussion 1958. PubMed ID: 18801533
[TBL] [Abstract][Full Text] [Related]
4. Prostate specific antigen screening for prostate cancer: knowledge of, attitudes towards, and utilization among primary care physicians.
Tasian GE; Cooperberg MR; Cowan JE; Keyashian K; Greene KL; Daniels NA; Carroll PR; Chan JM
Urol Oncol; 2012; 30(2):155-60. PubMed ID: 20800514
[TBL] [Abstract][Full Text] [Related]
5. Factors influencing use of the prostate-specific antigen screening test in primary care.
Moran WP; Cohen SJ; Preisser JS; Wofford JL; Shelton BJ; McClatchey MW
Am J Manag Care; 2000 Mar; 6(3):315-24. PubMed ID: 10977432
[TBL] [Abstract][Full Text] [Related]
6. Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer.
Bunting PS; Goel V; Williams JI; Iscoe NA
CMAJ; 1999 Jan; 160(1):70-5. PubMed ID: 9934349
[TBL] [Abstract][Full Text] [Related]
7. Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?
O'Dell KJ; Volk RJ; Cass AR; Spann SJ
J Fam Pract; 1999 Sep; 48(9):682-8. PubMed ID: 10498074
[TBL] [Abstract][Full Text] [Related]
8. Prostate-specific antigen assay using whole blood samples spotted on filter paper and its application to mass screening for prostate cancer.
Nanri M; Nanri K; Fujiyama C; Tokuda Y; Nakamura K; Uozumi J
Int J Urol; 2007 Jun; 14(6):505-9. PubMed ID: 17593094
[TBL] [Abstract][Full Text] [Related]
9. Current and projected annual direct costs of screening asymptomatic men for prostate cancer using prostate-specific antigen.
Krahn MD; Coombs A; Levy IG
CMAJ; 1999 Jan; 160(1):49-57. PubMed ID: 9934343
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study).
Hoffman RM; Couper MP; Zikmund-Fisher BJ; Levin CA; McNaughton-Collins M; Helitzer DL; VanHoewyk J; Barry MJ
Arch Intern Med; 2009 Sep; 169(17):1611-8. PubMed ID: 19786681
[TBL] [Abstract][Full Text] [Related]
11. Rising prostate specific antigen after radical prostatectomy: a case based review.
Nasr R; Goldenberg SL
Can J Urol; 2001 Aug; 8(4):1306-13. PubMed ID: 11564273
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis of cancer of the prostate (I): Advancements in knowledge and practice since the consensus conference of 1989. The "Cancer of the Prostate" subcommittee of the Committee of Oncology of the French Association of Urology].
Villers A; Grosclaude P; Haillot O; Abbou CC; Richard F; Boccon-Gibod L
Prog Urol; 1997 Jun; 7(3):508-15. PubMed ID: 9273082
[TBL] [Abstract][Full Text] [Related]
13. PSA quo vadis? It is reasonable to start with prostate-specific antigen testing at the age of 40!
Börgermann C; vom Dorp F; Swoboda A; Ketteniss O; Becker M; Rübben H
Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1190-5. PubMed ID: 21447776
[TBL] [Abstract][Full Text] [Related]
14. Prostate cancer and prostate-specific antigen (PSA) screening in Austria.
Vutuc C; Schernhammer ES; Haidinger G; Waldhör T
Wien Klin Wochenschr; 2005 Jul; 117(13-14):457-61. PubMed ID: 16091872
[TBL] [Abstract][Full Text] [Related]
15. The validity of male patients' self-reports regarding prostate cancer screening.
Jordan TR; Price JH; King KA; Masyk T; Bedell AW
Prev Med; 1999 Mar; 28(3):297-303. PubMed ID: 10072749
[TBL] [Abstract][Full Text] [Related]
16. Trends in prostate-specific antigen testing from 1995 through 2004.
Farwell WR; Linder JA; Jha AK
Arch Intern Med; 2007 Dec; 167(22):2497-502. PubMed ID: 18071173
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of prostate cancer in aging males receiving PSA (prostate specific antigen) screening test (A campaign for celebration of Siriraj Established Day).
Srinualnad S; Charoenkraikamol C; Toraksa S; Uiprasertkul M; Amornvesukit T; Taweemonkongsap T; Udompunturak S; Nualyong C; Tantiwong A
J Med Assoc Thai; 2006 Jan; 89(1):37-42. PubMed ID: 16583579
[TBL] [Abstract][Full Text] [Related]
18. The relationship between prostate cancer knowledge and beliefs and intentions to attend PSA screening among at-risk men.
Hevey D; Pertl M; Thomas K; Maher L; Chuinneagáin SN; Craig A
Patient Educ Couns; 2009 Feb; 74(2):244-9. PubMed ID: 18848753
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of PSA testing and effect of clinical indications on patterns of PSA testing in a population-based sample of Alberta men.
McGregor SE; Bryant HE; Brant RF; Corbett PJ
Chronic Dis Can; 2002; 23(3):111-9. PubMed ID: 12443567
[TBL] [Abstract][Full Text] [Related]
20. Prostate-specific antigen testing in general practice: a survey among 325 general practitioners in Denmark.
Jønler M; Eddy B; Poulsen J
Scand J Urol Nephrol; 2005; 39(3):214-8. PubMed ID: 16118092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
